| Literature DB >> 16931584 |
Tahar van der Straaten1, Dinemarie Kweekel, Marco Tiller, Judith Bogaartz, Henk-Jan Guchelaar.
Abstract
DNA repair enzymes play a pivotal role in platinum-based chemotherapy. Within the gene encoding for the base excision repair enzyme XRCC1, several nonsynonymous polymorphisms have been identified. It has been shown that the Arg399Gln single-nucleotide polymorphism results in a polymorphic enzyme that is less capable of initiating DNA repair. We developed a multiplex pyrosequence assay to simultaneously detect two nonsynonymous polymorphisms within the XRCC1 gene. Both of these polymorphisms resulted in amino acid changes: G/A in codon 399 changes Arg into Gln, and deletion of A in the second position of codon 576 results in a stopcodon. We established the frequency of these mutations in 270 patients suffering from colorectal cancer. Allele frequencies of G in second position of codon 399 and A in the second position codon 576 are 61.1 and 99.6%, respectively, in these patients. This fast and reliable method allows for simultaneous detection of the infrequent mutant C or CT alleles instead of the A deletion at codon 576. The method may be used in pharmacogenetic studies of platinum-based chemotherapy.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16931584 PMCID: PMC1867628 DOI: 10.2353/jmoldx.2006.060018
Source DB: PubMed Journal: J Mol Diagn ISSN: 1525-1578 Impact factor: 5.568